These results suggested that the PI3K-AKT pathway is associated with Lenvatinib resistance in HCC cells, and led us to focus on the EGFR-PI3K-AKT pathway and examine the effects of Curcumin for its ability to suppress this signaling pathway. The gene discussed is EGFR; the disease is hepatocellular carcinoma.